RecruitingPhase 3NCT07181109
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Sponsor: Alnylam Pharmaceuticals
Fargo, ND · +272 more sites
1 recruiting hypertension studies with a site in Fargo, ND.
Sponsor: Alnylam Pharmaceuticals
Fargo, ND · +272 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.